New Jersey

State of Hepatitis C
Medicaid Access:

C

New Jersey

Recommendations

  • Remove prior authorization for HCV treatment.
  • Publish FFS HCV coverage criteria.
  • Ensure transparency and parity across FFS and MCOs regarding HCV coverage criteria.
Read Full State Report

Feedback

See something here that doesn’t match your experience living in New Jersey? Tell us about it using the form below ↓

Report Feedback Form

Name(Required)
Email(Required)
Hidden
Please let us know if your experience is different from the data we have. Your feedback will help us show the most up-to-date information for each state.

Take Action

CONTACT YOUR POLICYMAKERS

Email your governor and state Medicaid director today urging them to commit to lifting these barriers for Medicaid beneficiaries to eliminate hepatitis C.

Contact Policymakers

SPREAD THE WORD

Access our infographics, social media toolkit and digital resources.

Spread the Word

JOIN THE NETWORK

Join the NVHR Voices4Hep network to connect with advocates across the country pushing for policies that eliminate hepatitis C by 2030.

Join the Network

@2023 HEPATITIS C: STATE OF MEDICAID ACCESS

As of August 2023, 25 states have removed prior authorization for most patients: AK, AR, CA, CO, DC, DE, FL, HI, ID, IL, IN, LA, MA, MI, MO, NH, NY, OK, OR, PA, RI, TX, VA, WA, WI.